lobbying_activities: 2186896

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2186896	5d5c62e4-4cd0-49f6-93dd-9a99b66f7e84	Q3	DAVIS & HARMAN LLP	11674	EMERGENT BIOSOLUTIONS, INC.	2018	third_quarter	DIS	FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Re-authorization of the Pandemic and All-Hazards Preparedness Act. NDAA - provisions related to biological and chemical defense.		20000		0	0	2018-10-17T09:32:16.287000-04:00